BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 28506439)

  • 1. Clinical Review: Loperamide Toxicity.
    Wu PE; Juurlink DN
    Ann Emerg Med; 2017 Aug; 70(2):245-252. PubMed ID: 28506439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loperamide Cardiac Toxicity: Pathophysiology, Presentation, and Management.
    Wu PE; Juurlink DN
    Can J Cardiol; 2022 Sep; 38(9):1378-1383. PubMed ID: 35430193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loperamide misuse to avoid opioid withdrawal and to achieve a euphoric effect: high doses and high risk.
    Lee VR; Vera A; Alexander A; Ruck B; Nelson LS; Wax P; Campleman S; Brent J; Calello DP
    Clin Toxicol (Phila); 2019 Mar; 57(3):175-180. PubMed ID: 30585509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Not your regular high: cardiac dysrhythmias caused by loperamide.
    Wightman RS; Hoffman RS; Howland MA; Rice B; Biary R; Lugassy D
    Clin Toxicol (Phila); 2016 Jun; 54(5):454-8. PubMed ID: 27022002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loperamide misuse and abuse.
    Miller H; Panahi L; Tapia D; Tran A; Bowman JD
    J Am Pharm Assoc (2003); 2017; 57(2S):S45-S50. PubMed ID: 28189538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpected Serious Cardiac Arrhythmias in the Setting of Loperamide Abuse.
    Rasla S; Parikh P; Hoffmeister P; St Amand A; Garas MK; El Meligy A; Minami T; Shah NR
    R I Med J (2013); 2017 Apr; 100(4):33-36. PubMed ID: 28375418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid misuse: containing harms.
    Peters-Watral B
    Int J Palliat Nurs; 2016 May; 22(5):213. PubMed ID: 27233007
    [No Abstract]   [Full Text] [Related]  

  • 8. Dysrhythmias with Loperamide Used for Opioid Withdrawal.
    Vithalani ND; Heron C; Rao RE; Cardell AF; Stephens MB
    J Am Board Fam Med; 2017; 30(6):832-834. PubMed ID: 29180560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intentional Misuse and Abuse of Loperamide: A New Look at a Drug with "Low Abuse Potential".
    Borron SW; Watts SH; Tull J; Baeza S; Diebold S; Barrow A
    J Emerg Med; 2017 Jul; 53(1):73-84. PubMed ID: 28501383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrocardiographic changes in loperamide toxicity: Case report and review of literature.
    Teigeler T; Stahura H; Alimohammad R; Kalahasty G; Koneru JN; Ellenbogen M; Ellenbogen KA; Padala SK
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2618-2626. PubMed ID: 31432581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse event detection using the FDA post-marketing drug safety surveillance system: Cardiotoxicity associated with loperamide abuse and misuse.
    Swank KA; Wu E; Kortepeter C; McAninch J; Levin RL
    J Am Pharm Assoc (2003); 2017; 57(2S):S63-S67. PubMed ID: 28073687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors for Opioid-Use Disorder and Overdose.
    Webster LR
    Anesth Analg; 2017 Nov; 125(5):1741-1748. PubMed ID: 29049118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing Prescription Opioid Misuse, Abuse and Overdose in Dentistry.
    Bragg LD
    J Okla Dent Assoc; 2015; 106(3):35-6. PubMed ID: 26480585
    [No Abstract]   [Full Text] [Related]  

  • 14. Loperamide-Associated Opioid Use Disorder and Proposal of an Alternative Treatment with Buprenorphine.
    Wolfrum LA; Nordmeyer AS; Racine CW; Nichols SD
    J Addict Med; 2019; 13(3):245-247. PubMed ID: 30379781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA Boxed Warning for Immediate-Release Opioids.
    Food And Drug Administration Public Health Service U S Department Of Health And Human Services
    J Pain Palliat Care Pharmacother; 2016 Jun; 30(2):141-5. PubMed ID: 27301692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loperamide and cardiac events: Is high-dose use still safe for chemotherapy-induced diarrhea?
    de Lemos ML; Guenter J; Kletas V
    J Oncol Pharm Pract; 2018 Dec; 24(8):634-636. PubMed ID: 28714380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular tachycardia associated with high-dose chronic loperamide use.
    Spinner HL; Lonardo NW; Mulamalla R; Stehlik J
    Pharmacotherapy; 2015 Feb; 35(2):234-8. PubMed ID: 25645123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergency department naloxone distribution: a Rhode Island department of health, recovery community, and emergency department partnership to reduce opioid overdose deaths.
    Samuels E
    R I Med J (2013); 2014 Oct; 97(10):38-9. PubMed ID: 25271659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loperamide Abuse Associated With Cardiac Dysrhythmia and Death.
    Eggleston W; Clark KH; Marraffa JM
    Ann Emerg Med; 2017 Jan; 69(1):83-86. PubMed ID: 27140747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loperamide Trends in Abuse and Misuse Over 13 Years: 2002-2015.
    Lasoff DR; Koh CH; Corbett B; Minns AB; Cantrell FL
    Pharmacotherapy; 2017 Feb; 37(2):249-253. PubMed ID: 27995643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.